{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2017", "item": "https://www.patentleaderboard.com/2017/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2017/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Simone Sciabola", "item": "https://www.patentleaderboard.com/2017/inventor/fl:si_ln:sciabola-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SS

Simone Sciabola — 1 Patent in 2017

Pfizer: 1 patents #98 of 344Top 30%
Cambridge, MA: #452 of 1,308 inventorsTop 35%
Massachusetts: #4,682 of 13,044 inventorsTop 40%
Overall (2017): #239,503 of 506,227Top 50%
1 Patents 2017

Issued Patents 2017

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9598421 Imidazopyridazine compounds Thomas Allen Chappie, Patrick Robert Verhoest, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal +2 more 2017-03-21 $801,098,000